| Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America ST Shulman, AL Bisno, HW Clegg, MA Gerber, EL Kaplan, G Lee, ... Clinical infectious diseases 55 (10), e86-e102, 2012 | 1773 | 2012 |
| The advisory committee on immunization practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020 SE Oliver MMWR. Morbidity and mortality weekly report 69, 2020 | 1694* | 2020 |
| Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update M Klompas, R Branson, EC Eichenwald, LR Greene, MD Howell, G Lee, ... Infection Control & Hospital Epidemiology 35 (8), 915-936, 2014 | 742 | 2014 |
| Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines KL Dooling, A Guo, M Patel, GM Lee, K Moore, EA Belongia, R Harpaz American Journal of Transplantation 18 (3), 756-762, 2018 | 680 | 2018 |
| Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices—United States, June 2021 JW Gargano MMWR. Morbidity and mortality weekly report 70, 2021 | 636 | 2021 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 584 | 2023 |
| Preventing tetanus, diphtheria, and pertussis among adults; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: recommendations of the Advisory … K Kretsinger, KR Broder, MM Cortese, P Joyce, I Ortega-Sanchez, ... | 544 | 2006 |
| Risk of anaphylaxis after vaccination in children and adults MM McNeil, ES Weintraub, J Duffy, L Sukumaran, SJ Jacobsen, NP Klein, ... Journal of Allergy and Clinical Immunology 137 (3), 868-878, 2016 | 495 | 2016 |
| Population genomics of post-vaccine changes in pneumococcal epidemiology NJ Croucher, JA Finkelstein, SI Pelton, PK Mitchell, GM Lee, J Parkhill, ... Nature genetics 45 (6), 656-663, 2013 | 409 | 2013 |
| Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged≥ 65 years: updated recommendations of the Advisory … A Matanock MMWR. Morbidity and mortality weekly report 68, 2019 | 381 | 2019 |
| Continued impact of pneumococcal conjugate vaccine on carriage in young children SS Huang, VL Hinrichsen, AE Stevenson, SL Rifas-Shiman, K Kleinman, ... Pediatrics 124 (1), e1-e11, 2009 | 354 | 2009 |
| Intussusception risk after rotavirus vaccination in US infants WK Yih, TA Lieu, M Kulldorff, D Martin, CN McMahill-Walraven, R Platt, ... New England Journal of Medicine 370 (6), 503-512, 2014 | 350 | 2014 |
| Antibiotic treatment of children with sore throat JA Linder, DW Bates, GM Lee, JA Finkelstein Jama 294 (18), 2315-2322, 2005 | 346 | 2005 |
| Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged≥ 65 years—United States, January–March 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 344 | 2021 |
| PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production LJ Celada, JA Kropski, JD Herazo-Maya, W Luo, A Creecy, AT Abad, ... Science translational medicine 10 (460), eaar8356, 2018 | 310 | 2018 |
| Risk of bacteremia for febrile young children in the post–Haemophilus influenzae type b era GM Lee, MB Harper Archives of pediatrics & adolescent medicine 152 (7), 624-628, 1998 | 307 | 1998 |
| Effect of nonpayment for preventable infections in US hospitals GM Lee, K Kleinman, SB Soumerai, A Tse, D Cole, SK Fridkin, T Horan, ... New England Journal of Medicine 367 (15), 1428-1437, 2012 | 296 | 2012 |
| Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis DA Salmon, M Proschan, R Forshee, P Gargiullo, W Bleser, DR Burwen, ... The Lancet 381 (9876), 1461-1468, 2013 | 258 | 2013 |
| Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update … HG Rosenblum MMWR. Morbidity and mortality weekly report 70, 2021 | 250 | 2021 |
| The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety MM McNeil, J Gee, ES Weintraub, EA Belongia, GM Lee, JM Glanz, ... Vaccine 32 (42), 5390-5398, 2014 | 242 | 2014 |
Eric S. WeintraubZweryfikowany adres z cdc.gov
